Éric Letouzé

13.0k total citations · 4 hit papers
59 papers, 5.3k citations indexed

About

Éric Letouzé is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Éric Letouzé has authored 59 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 26 papers in Cancer Research and 12 papers in Genetics. Recurrent topics in Éric Letouzé's work include Cancer Genomics and Diagnostics (16 papers), Epigenetics and DNA Methylation (11 papers) and Cancer, Hypoxia, and Metabolism (10 papers). Éric Letouzé is often cited by papers focused on Cancer Genomics and Diagnostics (16 papers), Epigenetics and DNA Methylation (11 papers) and Cancer, Hypoxia, and Metabolism (10 papers). Éric Letouzé collaborates with scholars based in France, United States and Canada. Éric Letouzé's co-authors include Jessica Zucman‐Rossi, Sandrine Imbeaud, Julien Caldéraro, Gabrielle Couchy, Paulette Bioulac‐Sage, Jean‐Charles Nault, Giuliana Amaddeo, Alexis Laurent, Anne‐Paule Gimenez‐Roqueplo and Charles Balabaud and has published in prestigious journals such as Journal of the American Chemical Society, Nature Communications and Nature Genetics.

In The Last Decade

Éric Letouzé

59 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma

2012 1.1k citations Cécile Guichard, Giuliana Amaddeo et al. Nature Genetics profile →
SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma

2013 551 citations Éric Letouzé, Céline Loriot et al. profile →
Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification

2017 532 citations Julien Caldéraro, Gabrielle Couchy et al. Journal of Hepatology profile →
Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas

2015 369 citations Jean‐Charles Nault, Sandrine Imbeaud et al. Nature Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Éric Letouzé France	30	2.6k	2.1k	1.1k	1.1k	895	59	5.3k
Gabrielle Couchy France	32	3.0k 1.2×	2.1k 1.0×	1.0k 0.9×	2.0k 1.8×	1.4k 1.6×	64	6.1k
Sandra Rebouissou France	28	2.5k 1.0×	1.6k 0.7×	1.2k 1.0×	1.8k 1.6×	1.0k 1.1×	40	5.0k
Olivier Govaere Belgium	30	1.4k 0.5×	675 0.3×	997 0.9×	1.5k 1.4×	981 1.1×	66	4.6k
Frank T. Kolligs Germany	40	2.9k 1.1×	809 0.4×	832 0.7×	459 0.4×	1.6k 1.8×	106	5.1k
Jun Akiba Japan	40	1.3k 0.5×	929 0.4×	1.0k 0.9×	781 0.7×	1.7k 1.9×	309	5.5k
Colin S. Cooper United Kingdom	31	3.9k 1.5×	1.6k 0.8×	781 0.7×	1.2k 1.0×	1.6k 1.8×	67	6.7k
T.R. Jeffry Evans United Kingdom	36	1.8k 0.7×	802 0.4×	440 0.4×	510 0.5×	1.9k 2.2×	107	4.4k
Paolo Michieli Italy	28	2.7k 1.0×	1.1k 0.5×	400 0.4×	1.3k 1.2×	1.8k 2.1×	41	4.6k
Oliver Stoeltzing United States	43	3.0k 1.2×	1.4k 0.7×	402 0.4×	323 0.3×	1.6k 1.7×	73	4.6k
Jing‐Ping Yun China	41	3.5k 1.4×	2.5k 1.2×	614 0.6×	398 0.4×	1.6k 1.8×	151	5.8k

Countries citing papers authored by Éric Letouzé

Since Specialization

Citations

This map shows the geographic impact of Éric Letouzé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éric Letouzé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éric Letouzé more than expected).

Fields of papers citing papers by Éric Letouzé

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Éric Letouzé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éric Letouzé. The network helps show where Éric Letouzé may publish in the future.

Co-authorship network of co-authors of Éric Letouzé

This figure shows the co-authorship network connecting the top 25 collaborators of Éric Letouzé. A scholar is included among the top collaborators of Éric Letouzé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Éric Letouzé. Éric Letouzé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Letouzé, Éric, Philippe Moreau, Nikhil Munshi, et al.. (2024). Mechanisms of resistance to bispecific T-cell engagers in multiple myeloma and their clinical implications. Blood Advances. 8(11). 2952–2959. 18 indexed citations

2.

Zucman‐Rossi, Jessica, et al.. (2023). Discovering cryptic splice mutations in cancers via a deep neural network framework. NAR Cancer. 5(2). zcad014–zcad014. 3 indexed citations

3.

Bayard, Quentin, Camille Péneau, Sandrine Imbeaud, et al.. (2022). Structure, Dynamics, and Impact of Replication Stress–Induced Structural Variants in Hepatocellular Carcinoma. Cancer Research. 82(8). 1470–1481. 3 indexed citations

4.

Molina, Laura, Eric Trépo, Quentin Bayard, et al.. (2022). Bi-allelic hydroxymethylbilane synthase inactivation defines a homogenous clinico-molecular subtype of hepatocellular carcinoma. Journal of Hepatology. 77(4). 1038–1046. 19 indexed citations

5.

Foll, Matthieu, Marie Brevet, Martine Antoine, et al.. (2022). Detection of acquired TERT amplification in addition to predisposing p53 and Rb pathways alterations in EGFR-mutant lung adenocarcinomas transformed into small-cell lung cancers. Lung Cancer. 167. 98–106. 18 indexed citations

6.

An, Jihyun, Deokhoon Kim, Ji‐Hyun Song, et al.. (2021). Comprehensive characterization of viral integrations and genomic aberrations in HBV‐infected intrahepatic cholangiocarcinomas. Hepatology. 75(4). 997–1011. 17 indexed citations

7.

Moog, Sophie, Aurélie Morin, Géraldine Gentric, et al.. (2021). Loss of SDHB Promotes Dysregulated Iron Homeostasis, Oxidative Stress, and Sensitivity to Ascorbate. Cancer Research. 81(13). 3480–3494. 40 indexed citations

8.

Caruso, Stefano, Tiziana La Bella, Sandrine Imbeaud, et al.. (2019). Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response. Gastroenterology. 157(3). 760–776. 133 indexed citations

9.

Buffet, Alexandre, Aurélie Morin, Luis-Jaime Castro-Vega, et al.. (2018). Germline Mutations in the Mitochondrial 2-Oxoglutarate/Malate Carrier SLC25A11 Gene Confer a Predisposition to Metastatic Paragangliomas. Cancer Research. 78(8). 1914–1922. 99 indexed citations

10.

Renault, Victor, Jörg Tost, Shufang Renault, et al.. (2017). aCNViewer: Comprehensive genome-wide visualization of absolute copy number and copy neutral variations. PLoS ONE. 12(12). e0189334–e0189334. 6 indexed citations

11.

Letouzé, Éric, Jayendra Shinde, Victor Renault, et al.. (2017). Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis. Nature Communications. 8(1). 1315–1315. 176 indexed citations

12.

Bally, Cécile, Jacqueline Lehmann‐Che, Bruno Cassinat, et al.. (2016). Whole Exome Analysis of Relapsing Patients with Acute Promyelocytic Leukemia. Blood. 128(22). 2892–2892. 1 indexed citations

13.

Villanueva, Augusto, Anna Portela, Sergi Sayols, et al.. (2015). DNA methylation‐based prognosis and epidrivers in hepatocellular carcinoma. Hepatology. 61(6). 1945–1956. 315 indexed citations

14.

Rebouissou, Sandra, Aurélie Hérault, Éric Letouzé, et al.. (2012). CDKN2A homozygous deletion is associated with muscle invasion in FGFR3 ‐mutated urothelial bladder carcinoma. The Journal of Pathology. 227(3). 315–324. 77 indexed citations

15.

Manceau, Gilles, Éric Letouzé, Cécile Guichard, et al.. (2012). Recurrent inactivating mutations of ARID2 in non‐small cell lung carcinoma. International Journal of Cancer. 132(9). 2217–2221. 58 indexed citations

16.

Guichard, Cécile, Giuliana Amaddeo, Sandrine Imbeaud, et al.. (2012). Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nature Genetics. 44(6). 694–698. 1072 indexed citations breakdown →

17.

Burnichon, Nelly, Alexandre Buffet, Béatrice Parfait, et al.. (2012). Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma. Human Molecular Genetics. 21(26). 5397–5405. 106 indexed citations

18.

Letouzé, Éric, Yves Allory, Marc A. Bollet, François Radvanyi, & Frédéric Guyon. (2010). Analysis of the copy number profiles of several tumor samples from the same patient reveals the successive steps in tumorigenesis. Genome biology. 11(7). R76–R76. 78 indexed citations

19.

Letouzé, Éric, Yves Allory, Marc A. Bollet, François Radvanyi, & Frédéric Guyon. (2010). Analysis of the copy number profiles of several tumor samples from the same patient reveals the successive steps in tumorigenesis. Genome Biology. 11(Suppl 1). P25–P25. 2 indexed citations

20.

Shepherd, Nicholas E., et al.. (2006). Modular α-Helical Mimetics with Antiviral Activity against Respiratory Syncitial Virus. Journal of the American Chemical Society. 128(40). 13284–13289. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact